Skip to content
Inflammx Therapeutics, Inc. logo

Inflammx Therapeutics, Inc. Alternatives & Competitors

12 companies similar to Inflammx Therapeutics, Inc. — Modulation of Inflammasome mediated Autoinflammation - in Ophthalmology, Nephro...

Companies similar to Inflammx Therapeutics, Inc.

Azome Therapeutics logo — alternative to Inflammx Therapeutics, Inc.

Azome Therapeutics

Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases

Osprey Pharmaceuticals USA logo — alternative to Inflammx Therapeutics, Inc.

Osprey Pharmaceuticals USA

Pioneering protein therapeutics to combat inflammation and immune diseases with targeted f...

Cell Care Therapeutics logo — alternative to Inflammx Therapeutics, Inc.

Cell Care Therapeutics

Developing first-in-class stem cell derived biopharmaceuticals to treat inflammatory and d...

Therini Bio, Inc. logo — alternative to Inflammx Therapeutics, Inc.

Therini Bio, Inc.

A new approach to block vascular-mediated inflammation

Rival Readout

Competing with Inflammx Therapeutics, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Nicox logo — alternative to Inflammx Therapeutics, Inc.

Nicox

Maintain vision and improve ocular health

Bionure logo — alternative to Inflammx Therapeutics, Inc.

Bionure

Clinical stage biotech developing new drugs for CNS diseases.

D-Sight S.L. logo — alternative to Inflammx Therapeutics, Inc.

D-Sight S.L.

Spin-off company from VHIR developing new innovative treatments for neurodegenerative dise...

Inimex Pharmaceuticals logo — alternative to Inflammx Therapeutics, Inc.

Inimex Pharmaceuticals

Advancing health by harnessing the body's natural defenses with innovative, non-inflammato...

Proprius Pharmaceuticals logo — alternative to Inflammx Therapeutics, Inc.

Proprius Pharmaceuticals

A San Diego innovator specializing in rheumatology and autoimmune care, offering promising...

KalVista Pharmaceuticals, Inc. logo — alternative to Inflammx Therapeutics, Inc.

KalVista Pharmaceuticals, Inc.

Creating a new generation of small molecule protease inhibitors for HAE and DME.

Montis Biosciences logo — alternative to Inflammx Therapeutics, Inc.

Montis Biosciences

Pioneering next-gen therapeutics to harness C1q's central role in neuroinflammatory diseas...

Ampio Pharmaceuticals, Inc. logo — alternative to Inflammx Therapeutics, Inc.

About Inflammx Therapeutics, Inc.

Brian Levy is a clinical stage company founded in 2005 and headquartered in the United States. The company focuses on developing an orally administered compound to inhibit the dysregulated NLRP3 Inflammasome pathway of autoinflammation. Their Phase 2 asset, Xiflam, is set to undergo clinical trials in 2022 for indicati...

Business keywords

Biopharmaceuticals, Ophthalmology, Nephropathy, Neurodegenerative Diseases, Clinical Stage Company, Drug Development, Inflammation, Autoinflammation, NLRP3 Inflammasome Pathway, Diabetic Macular Edema, Diabetic Retinopathy, Gap Junction Channel Modulation, Drug Candidates, Therapeutics Development, San Diego

Frequently Asked Questions

Companies similar to Inflammx Therapeutics, Inc. include Azome Therapeutics, Osprey Pharmaceuticals USA, Cell Care Therapeutics, Therini Bio, Inc., Nicox. They work in Biotechnology and Health Care and share Inflammx Therapeutics, Inc.'s focus on biopharmaceuticals, drug development and ophthalmology.
Bounce Watch lists 12 companies that share Inflammx Therapeutics, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.
Brian Levy is a clinical stage company founded in 2005 and headquartered in the United States. The company focuses on developing an orally administered compound to inhibit the dysregulated NLRP3 Inflammasome pathway of autoinflammation. Their Phase 2 asset, Xiflam, is set to undergo clinical trials in 2022 for indicati...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Inflammx Therapeutics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Inflammx Therapeutics, Inc. on 14 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout